Juan Carlos Andreu-Ballester

9PUBLICATIONS
19CO-AUTHORS
Innate immunityCancer cell biologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2026
Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS-CoV-2 Vaccination.

|Jul 28, 2026
Downregulation of CD132 in Colonic Adenomas and Cancer Is Associated with γδ T-Cell Loss, Increased Apoptosis, and Microsporidia Infection.

|Jul 28, 2026
SARS-CoV-2 mRNA Vaccination Induces Reduced T-Cell Apoptosis in Patients with Solid Tumors.

|May 04, 2026
Dysregulated IL-7/IL-7R-CD132 Axis and Intestinal Microsporidiosis in Crohn's Disease.

|Aug 28, 2025
Prevalence of Anti-Anisakis simplex Antibodies in a Cohort of Patients with Inflammatory Bowel Disease in Norway.

María P de la Hoz-Martín, Juan González-Fernández, Juan Carlos Andreu-Ballester

|Dec 27, 2024
Increased Levels of Anti-Anisakis Antibodies During Hospital Admission in Septic Patients.

Juan Carlos Andreu-Ballester, Amparo Navarro, Miguel Angel Arribas

Pageof 2

Frequent Collaborators

6 joint publications

Carmen Cuéllar

3 joint publications

Lorena Galindo-Regal

3 joint publications

Antonio Llombart-Cussac

3 joint publications

Juan González-Fernández